Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia

NOVEL DRUGS

Interview with E.A. Nikitin1

1 MD, DSci, Head of Day Patient Department of Hematology, Oncology and Chemotherapy, SP Botkin Municipal Clinical Hospital, Moscow

Interviewer: Prof. E.A. Osmanov, DSci

Read in PDF (RUS)pdficon